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Background: Contradictory data on consequences of prolonged high-fat diet requires a detailed study of the influence
of nutritional high-fat load mechanisms on the peculiarity of lipid metabolism in blood and liver. The present study was
undertaken to investigate the fatty acid composition of polar and neutral lipids of the blood plasma, erythrocytes and
liver in Wistar rats under the conditions of a prolonged high-fat diet.
Methods: The study was conducted on 60 adult white male Wistar rats. The animals were fed on a high-fat diet consisted
of the beef fat and cholesterol (19% and 2% of the total diet, respectively) up to 180 days. The fatty acid composition of
the polar and neutral lipids of plasma, erythrocytes and liver were analyzed by the gas chromatography. Statistical data
processing was performed by the methods of descriptive statistics with Statistica 6.0.
Results: The prolonged unbalanced diet rich in cholesterol and saturated fatty acids resulted in compensatory biosynthesis
of the fatty acids in the rat’s liver, the inhibition of synthesis of apoproteins and lipoproteins, disruption of the
active transport of fatty acids to tissue cells. This launched the accumulation of 20:4n-6, 20:5n-3, 22:5n-3, and
22:6n-3 in the liver and blood plasma and deficiency of 18:2n-6, 20:5n-3 and 22:6n-3 in the erythrocytes.
Conclusions: Adaptive adjustment of lipid metabolism un0064er conditions of the high-fat diet induced inhibition of
the formation of lipoproteins (VLDL cholesterol) in the liver, compensatory synthesis of 18:1n-9, 20:5n-3, and 20:3n-6
with primary esterification of PUFA n-3 series to neutral lipids.
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Alimentary factors, in particular saturated fats and choles-
terol, can significantly alter the liver metabolic processes,
affect lipid metabolism, biosynthesis of the fatty acids and
the lipoproteins formation [1-3]. The results of the experi-
mental and clinical observations have contributed to clari-
fication of the role of fatty acids varying in the degree of
saturation in the development of many diseases such as
atherosclerosis, diabetes and steatohepatitis [4,5]. How-
ever, the concept of the relationship between increased
consumption of the saturated fatty acids and the develop-
ment of hyperlipidaemia with subsequent atherosclerosis
and steatohepatitis is currently subject to criticism. Some
studies have shown that consumption of triacylglycerol
(TAG) rich in palmitic acid does not affect the levels of* Correspondence: nzhukova35@list.ru
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unless otherwise stated.high density lipoprotein (HDL), cholesterol and total chol-
esterol in the blood [6]. There is evidence that excessive
consumption of stearic acid lowers the level of low density
lipoprotein (LDL) cholesterol and HDL cholesterol [7].
However, a decrease in the expression of the apo-B, E re-
ceptor of LDL at an increased consumption of saturated
fats contributes to the accumulation of LDL and the de-
velopment of hypercholesterolemia [8]. The experiments
with rat model of lipid steatohepatitis have established that
addition of saturated FA into the diet prevents liver necro-
sis and inflammation [8].
The regulatory effect of the alimentary fats on the lipid
metabolism is realized at the level of modulation of the
specific transcription factors expression involved in the
metabolism of fatty acids - PGC-1β (peroxisome-prolif-
erator-activated receptor-gamma coactivator 1 beta),
HNF4 (hepatocyte nuclear factor 4), PPAR (peroxisome
proliferator-activated receptor), and SREBP1 (sterol regu-
latory element-binding protein) [8-11]. At an excessivel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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sufficient exogenous inflow of physiologically important
essential fatty acids, the organism launches the particular
mechanisms to activate the endogenous synthesis of
monounsaturated and polyunsaturated fatty acids. This
mechanism is mediated through the activation of the Δ9
desaturase, Δ6 desaturase and Δ5 desaturase and elon-
gases. As a result, there occurs the activation of the com-
pensatory de novo synthesis of monounsaturated and
polyunsaturated fatty acids by hepatocytes. Modification
of the fatty acids in the liver is a compensatory response
that prevents deficiency of the physiologically important
fatty acids. We may assume that in response to the high-
fat diet in the liver two opposing (by its physiological role)
processes are implemented: the accumulation of the diet-
ary exogenous saturated lipids and the endogenous syn-
thesis of monounsaturated and polyunsaturated fatty
acids. The change of the lipid metabolism in the liver
under the influence of the nutritional factors may be
reflected in the transformation of the fatty acid compos-
ition in lipids of the blood plasma, cell membranes of the
peripheral organs, erythrocytes in particular [12,13]. The
fatty acid composition of erythrocyte membranes was used
as a diagnostic criterion for assessment of different dis-
eases [14,15], therefore the red blood cells were taken as a
universal model for the study of pathological reactions.
Contradictory information requires a detailed study of
the influence of nutritional high-fat load mechanisms on
the peculiarity of lipid metabolism in blood and liver of
rats. The aim of the present work was to study the fatty
acid composition of polar and neutral lipids of the blood
plasma, erythrocytes and liver in Wistar rats under the
conditions of a prolonged high-fat diet.
Methods
Subjects
Experiments were carried out on 60 Wistar male rats.
The following groups of animals were formed: Experi-
ment 1 on rats fed the experimental diet for 30 days; Ex-
periment 2, the experimental diet for 90 days; and
Experiment 3, the experimental diet for 180 days. The
control group 1 included 30 intact males kept on a
standard vivarium diet for 30 days, the same for 90 days
(control group 2), and the same for 180 days (control
group 3). Each test group was compared with the re-
spective control group, receiving the diet during the
same time. The experimental diet contained beef fat
(19% of the total diet) and cholesterol (2% of the total
diet) [5] additionally to the standard ration.
The fatty acid composition of beef fat included satu-
rated FA (12:0, 14:0, 16:0, and 18:0) to 66% of the total
FA, monounsaturated FA (35%), and polyunsaturated
fatty acids (2%). Animal euthanasia was carried out by
decapitation under ether anesthesia in accordance withthe requirements of the European Convention for the
Protection of Experimental Animals, 86/609 EEC [16].
The euthanasia schedule was as follows: rats of the test
group 1 and the respective control groups were eutha-
nized on the 31st day; rats of the test group 2 and the
respective control group 2 were euthanized on the 91st
day; rats of the test group 3 and the respective control
group 3 were euthanized on the 181st day. Morning fast-
ing blood for research was taken from jugular vein of
the rats after decapitation. The liver for fatty acid re-
search was removed from rats after decapitation. The
body weight of rats was recorded before and after the
experiment.
Lipid and fatty acid analysis
Lipid profile of the blood serum was studied on a bio-
chemical analyzer FP-901 («Labsistems», Finland). Total
cholesterol, triacylglyceride (TAG), and high-density lipo-
protein (HDL) cholesterol were measured. The concentra-
tion of LDL cholesterol and very low density lipoprotein
(VLDL) cholesterol were calculated by the Friedwald’s for-
mula. The results are expressed in mmol/L.
LDL cholesterol ¼ Total cholesterol VLDL cholesterol
HDL cholesterol;
VLDL cholesterol ¼ TAG=2:2:
The index of atherogenicity (IA) was calculated as
IA = (Total cholesterol – HDL)/HDL cholesterol.
Lipids were extracted using the solvent system chloro-
form – methanol, 1:2 (v/v), and then chloroform -
methanol (1:1 v/v) and 0.9% sodium chloride were added
until a complete phase separation is reached [17]. Separ-
ation of phospholipids and triacylglycerols from the lipids
of the liver was performed by thin-layer chromatography
(TLC) on silica gel using a solvent system, which consisted
of hexan/diethyl ether/acetic acid (80:20:1, v/v). Fatty acid
methyl esters (FAME) were obtained by a sequential treat-
ment of the total lipids with 1% sodium methylate/metha-
nol and 5% HCl/methanol according to Carreau and
Dubacq [18] and purified by preparative silica gel thin-
layer chromatography, using the silica gel plates developed
in benzene. MEFA were analyzed on a Shimadzu GC-2010
(Japan) gas chromatograph equipped with a flame ioni-
zation detector, using a fused silica capillary column
(Supelcowax-10, 30 m × 0.25 mm i. d. Supelco, Bellefonte,
PA). Helium was used as a carrier gas at a linear velocity
of 30 cms–1. The column temperature was 210°C, injector
and detector temperatures were 250°C. Fatty acids were
identified by a comparison with standard mixtures and
equivalent chain length values [19]. The results were
expressed in relative % of total FA.
Zhukova et al. Lipids in Health and Disease 2014, 13:49 Page 3 of 8
http://www.lipidworld.com/content/13/1/49Statistical analysis
Statistical data processing was performed using the ap-
plied program statistics with Statistica 6.1. The differ-
ences in contents of the fatty acids between control
groups and experimental groups of the rats were tested
using a Student’s t-test. Differences were considered sta-
tistically significant at P < 0.05.
Results and discussion
Biometrics
The body weight of rats of the experimental group 1,
which consumed the high-fat diet for 30 days, increased
by 151 ± 11 g, which is by 84% higher compared to the
initial weight. After 90 days of the experiment, the body
weight of the animals of the experimental group 2 in-
creased by 182 ± 6 g. In rats of the experimental group 3
(180 days of the high-fat diet), the body weight increased
by 295 ± 65 g (2.6 times) of the initial weight. All values
are significant at P < 0.001.
Lipids in blood serum
High-fat load for 30 days resulted in increased levels of total
cholesterol, triacylglycerols, LDL cholesterol, and VLDL
cholesterol in the rats’ blood serum (Table 1). After 90 days
of high fat load, we detected a reduced concentration of
TAG and VLDL cholesterol and an increased content of
HDL cholesterol in the blood of rats and decrease of IA.
On the 180th day of high-fat diet, the total cholesterol and
LDL cholesterol contents in rats’ blood serum were in-
creased, while the level of VLDL cholesterol remained low.
Dietary saturated fats modify cholesterol metabolism and
increase significantly the concentration of HDL cholesterol
and rise triglyceride accumulation in mouse after three
weeks of high fat diet [20]. The obtained data demonstrate
that alimentary fats exert a distinctly pronounced hyperlip-
idemic effect only on the 30th day of the experiment.
It is known that an increase in the blood lipid content
after consumption of food is a normal physiological
process of the digestive and lipid transport systems. The




Total cholesterol, mmol/L 1.49 ± 0.04 3.68 ± 0.04*** 1.5
Triacylglycerols, mmol/L 1.19 ± 0.04 1.90 ± 0.06*** 1.1
LDL cholesterol, mmol/L 0.29 ± 0.02 2.34 ± 0.11*** 0.2
VLDL cholesterol, mmol/L 0.54 ± 0.02 0.85 ± 0.03*** 0.5
HDLcholesterol, mmol/L 0.67 ± 0.04 0.28 ± 0.02*** 0.6
Atherogenicity index 1.36 ± 0.15 11.87 ± 1.55*** 1.4
Mean ± m, n = 10.
Note: Asterisks indicate significant differences of lipid contents between rats from exp
Asterisks indicate significant differences of lipid contents between rats from experimenminutes after consumption of food rich in fat. In our
study, the fasting blood was taken from the rats in the
morning. The minimum period of time between the last
food consumption by test animals and the blood sampling
was 12 hours. Accordingly, with this time interval, the
changes in the content of atherogenic lipoproteins in the
blood serum that were recorded on the 90th and the
180th days of the experiment are the result of a decrease
in the synthesis of apoproteins and VLDL assembly in the
liver. Ration rich in saturated fats may inhibit the VLDL
synthesis in the liver [21,22]. Since VLDL transport TAG
from the liver to organs and tissues in the body, insuffi-
cient VLDL synthesis causes accumulation of TAG in adi-
pose and parenchymal tissues and in the liver.
Concentration of LDL in the blood is depends on the ac-
tivity of their formation from lipoproteins of VLDL and the
efficiency of LDL capture by apoB-100 receptors. Conse-
quently, the accumulation of LDL cholesterol in the blood
and interstitial fluid occurs at the blockage of the apoB-100
receptor-mediated endocytosis of LDL and at inhibition of
hydrolysis of TAG contained in the VLDL [23]. An indica-
tor of such disorders is an increase in the LDL concentra-
tion in the blood. The primary role of LDL is to transfer of
PUFA to the cells in the form of non-polar esters of choles-
terol. Blockage of active LDL capture by cells can lead to
development of PUFA deficiency in the cells. A direct evi-
dence of such disorder can be an increased circulation of
lipids rich in unsaturated FA in blood at a simultaneous
deficit of these FA in cell membranes. In order to confirm
this assumption and to establish the features of lipid ex-
change during a prolonged nutrition load, we have studied
the fatty acid composition of polar and neutral lipids in
blood plasma and in red blood cells of rats in the dynamics
of the impact of high fat diet.
Fatty acids of blood plasma and erythrocytes
It was found that the levels of 14:0 and 15:0 in the pool
of phospholipids (PL), TAG and sterol esters (ES) in the
rats’ blood were on the 30th day of the high-fat load in-
creased (Table 2). As compared with the control group,days 180 days
ntrol Experiment Control Experiment
6 ± 0.11 1.64 ± 0.08 1.59 ± 0.04 ***2.82 ± 0.17
4 ± 0.01 ***0.51 ± 0.05xxx 1.18 ± 0.04 ***0.52 ± 0.08xxx
5 ± 0.04 ***0.90 ± 0.12xxx 0.33 ± 0.02 ***1.84 ± 0.17x
5 ± 0.02 ***0.23 ± 0.01xxx 0.64 ± 0.05 ***0.22 ± 0.02xxx
9 ± 0.03 0.50 ± 0.08xxx 0.74 ± 0.06 0.75 ± 0.15xxx
9 ± 0.13 *2.9 ± 0.35xxx 1.50 ± 0.21 ***2.44 ± 0.8xxx
erimental group and corresponding control group: *for P < 0.05; ***for P < 0.001.
tal group and preceding experimental group: xfor P < 0.05; xxxfor P < 0.001.
Table 2 The content of fatty acids (wt%) in plasma and erythrocytes of rats at a high-fat load
Fatty acid Source High-fat load
30 days 90 days 180 days
Control Experiment Control Experiment Control Experiment
14:0 Erythrocyte 0.52 ± 0.04 *0.83 ± 0.08 / 1.6↑ 0.48 ± 0.04 0.5 ± 0.06 0.50 ± 0.03 ***1.01 ± 0.12 / 2↑
Plasma PL 0.50 ± 0.04 ***1.22 ± 0.20 / 2.2↑ 0.62 ± 0.04 0.57 ± 0.05 0.60 ± 0.07 **0.37 ± 0.04 / 1.6↓
Plasma TAG 1.43 ± 0.10 *1.71 ± 0.10 / 1.2↑ 1.50 ± 0.10 1.53 ± 0.15 1.48 ± 0.10 *0.87 ± 0.11 / 1.7↓
Plasma ES 1.05 ± 0.06 1.23 ± 0.01 0.95 ± 0.09 0.84 ± 0.06 1.10 ± 0.05 ***0.42 ± 0.05 / 2.5↓
15:0 Erythrocyte 0.52 ± 0.04 0.58 ± 0.07 0.72 ± 0.06 **0.43 ± 0.02 / 1.7↓ 0.76 ± 0.07 *0.56 ± 0.04 / 1.4↓
Plasma PL 0.75 ± 0.06 ***1.33 ± 0.07 / 1.7↑ 0.72 ± 0.05 ***0.45 ± 0.02 / 1.6↓ 0.68 ± 0.05 ***0.40 ± 0.01 / 1.7↓
Plasma TAG 0.92 ± 0.08 ***1.55 ± 0.07 / 1.6↑ 0.90 ± 0.10 0.86 ± 0.05 0.94 ± 0.07 **0.52 ± 0.08 / 1.8↓
Plasma ES 0.80 ± 0.02 ***1.36 ± 0.09 / 1.7↑ 0.84 ± 0.04 ***0.41 ± 0.03 / 2↓ 0.93 ± 0.02 ***0.35 ± 0.01 / 2.6↓
16:0 Erythrocyte 23.72 ± 0.84 24.38 ± 0.57 24.12 ± 0.68 ***28.6 ± 0.5 / 1.2↑ 24.72 ± 0.74 **27.6 ± 1.4 / 1.1↑
Plasma PL 28.50 ± 0.33 27.68 ± 0.56 26.50 ± 0.43 25.64 ± 0.83 28.70 ± 0.30 27.02 ± 0.36
Plasma TAG 28.16 ± 2.24 26.42 ± 0.68 27.60 ± 2.00 24.23 ± 1.66 28.86 ± 1.80 **22.2 ± 0.52 / 1.3↓
Plasma ES 17.32 ± 3.49 15.67 ± 1.66 17.18 ± 1.00 ***11.47 ± 0.43 / 1.5↓ 17.00 ± 0.09 ***11.32 ± 0.12 / 1.5↓
16:1n-7 Erythrocyte 1.90 ± 0.25 1.83 ± 0.12 1.88 ± 0.22 ***0.83 ± 0.05 / 2.3↓ 2.04 ± 0.30 2.04 ± 0.21
Plasma PL 1.2 ± 0.1 ***3.31 ± 0.40 / 2.7↑ 1.1 ± 0.2 0.91 ± 0.07 1.1 ± 0.6 1.17 ± 0.14
Plasma TAG 6.57 ± 0.34 *8.67 ± 0.14 / 1.3↑ 7.56 ± 0.30 ***2.53 ± 0.27 / 3↓ 8.10 ± 0.46 *2.72 ± 0.39 / 3↓
Plasma ES 5.35 ± 0.59 ***8.14 ± 0.77 / 1.6↑ 5.20 ± 0.40 *3.28 ± 57.14 / 1.6↓ 5.15 ± 0.90 4.75 ± 0.19
18:0 Erythrocyte 10.10 ± 0.50 **14.68 ± 0.48 / 1.4↑ 10.7 ± 0.45 ***17.3 ± 0.57 / 1.7↑ 9.9 ± 0.40 ***13.9 ± 1.77 / 1.4↑
Plasma PL 19.00 ± 0.37 *21.67 ± 0.94 / 1.1↑ 19.40 ± 0.67 ***23.23 ± 0.14 / 1.2↑ 18.70 ± 0.70 18.97 ± 0.72
Plasma TAG 5.00 ± 0.03 *3.00 ± 0.16 / 1.6↓ 4.80 ± 0.10 ***8.72 ± 0.91 / 1.8↑ 5.10 ± 0.30 4.92 ± 0.34
Plasma ES 3.75 ± 0.54 3.72 ± 0.46 3.45 ± 0.94 3.35 ± 0.22 3.70 ± 0.50 3.15 ± 0.56
18:1n-9 Erythrocyte 7.66 ± 0.57 **11.45 ± 1.22 / 1.5↑ 7.51 ± 0.70 **10.5 ± 0.31 / 1.4↑ 8.16 ± 0.67 **11.2 ± 1.38 / 1.4↑
Plasma PL 6.77 ± 0.41 7.67 ± 0.28 6.14 ± 0.50 6.91 ± 2.09 6.35 ± 0.60 *9.52 ± 0.34 / 1.5↑
Plasma TAG 25.27 ± 2.26 26.5 ± 2.36 27.70 ± 2.20 30.66 ± 1.87 26.10 ± 1.20 ***36.55 ± 1.14 / 1.4↑
Plasma ES 22.30 ± 3.7 ***11.5 ± 0.9 / 2↓ 21.64 ± 2.0 ***36.8 ± 2.7 / 1.7↑ 21.30 ± 1.70 ***46.5 ± 0.8 / 2.2↑
18:2n-6 Erythrocyte 14.02 ± 0.64 ***9.78 ± 0.23 / 1.4↓ 13.12 ± 0.64 12.6 ± 0.4 14.62 ± 0.84 **11.3 ± 0.97 / 1.3↓
Plasma PL 18.50 ± 0.6 18.85 ± 1.05 18.9 ± 0.60 18.12 ± 1.21 17.8 ± 0.50 18.30 ± 0.20
Plasma TAG 19.62 ± 2.86 ***15.3 ± 1.1 / 1.2↓ 20.20 ± 2.00 20.23 ± 1.40 18.82 ± 1.80 *17.12 ± 0.16 / 1.1↓
Plasma ES 19.25 ± 1.19 19.17 ± 1.35 20.25 ± 1.10 21.08 ± 0.96 18.40 ± 1.00 ***13.12 ± 0.2 / 1.4↓
20:3n-9 Erythrocyte 0.35 ± 0.12 tr 0.27 ± 0.10 0.17 ± 0.03 0.31 ± 0.10 ***0.95 ± 0.09 / 3↑
Plasma PL 0.55 ± 0.02 ***0.27 ± 0.02 / 2↓ 0.54 ± 0.10 ***0.25 ± 0.09 / 2↓ 0.62 ± 0.12 0.65 ± 0.02
Plasma TAG 0.72 ± 0.05 ***0.30 ± 0.01 / 2.4↓ 0.77 ± 0.08 0.73 ± 0.12 0.74 ± 0.06 ***1.45 ± 0.34/ 2↑
Plasma ES 0.96 ± 0.17 0.83 ± 0.31 0.94 ± 0.14 ***0.45 ± 0.05 / 2.1↓ 0.89 ± 0.20 0.75 ± 0.17
20:3n-6 Erythrocyte 0.60 ± 0.13 0.88 ± 0.09 0.62 ± 0.10 **1.23 ± 0.06 / 2↑ 0.70 ± 0.10 0.9 ± 0.08
Plasma PL 1.77 ± 0.39 1.38 ± 0.12 1.82 ± 0.30 2.05 ± 0.14 2.10 ± 0.70 *3.05 ± 0.29
Plasma TAG 0.77 ± 0.38 ***0.27 ± 0.20 / 2.8↓ 0.67 ± 0.30 0.51 ± 0.06 0.70 ± 0.30 0.72 ± 0.19
Plasma ES 0.42 ± 0.06 *0.66 ± 0.08 / 1.5↑ 0.52 ± 0.10 0.55 ± 0.06 0.48 ± 0.09 0.47 ± 0.02
20:4n-6 Erythrocyte 6.78 ± 1.70 ***21.27 ± 1.92 / 3.1↑ 6.80 ± 1.20 ***16.3 ± 0.5 / 2.4↑ 6.90 ± 1.72 ***15.9 ± 0.94 / 2.3↑
Plasma PL 12.2 ± 0.72 ***7.56 ± 0.62 / 1.7↓ 12.8 ± 0.80 13.66 ± 0.72 13.0 ± 0.80 **9.80 ± 0.60 / 1.3↓
Plasma TAG 2.45 ± 0.65 ***0.87 ± 0.16 / 2.7↓ 2.50 ± 0.60 2.38 ± 0.25 2.20 ± 0.50 2.11 ± 0.32
Plasma ES 28.73 ± 7.34 **18.84 ± 2.73 / 1.5↓ 30.54 ± 3.30 ***10.96 ± 0.86 / 2.8↓ 28.50 ± 2.40 ***10.55 ± 0.90 / 2.7↓
20:5n-3 Erythrocyte 0.90 ± 0.13 0.73 ± 0.09 0.86 ± 0.10 *0.58 ± 0.05 0.93 ± 0.12 **0.68 ± 0.05
Plasma PL 0.42 ± 0.13 ***1.55 ± 0.18 / 3.7↑ 0.48 ± 0.10 0.62 ± 0.11 0.50 ± 0.10 0.50 ± 0.10
Plasma TAG 0.70 ± 0.03 ***1.17 ± 0.11 / 1.6↑ 0.72 ± 0.08 *0.92 ± 0.13 / 1.3↑ 0.73 ± 0.07 **0.95 ± 0.05 / 1.3↑
Plasma ES 0.70 ± 0.20 tr 0.75 ± 0.10 ***1.24 ± 0.12 / 1.7↑ 0.80 ± 0.20 0.95 ± 0.11
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Table 2 The content of fatty acids (wt%) in plasma and erythrocytes of rats at a high-fat load (Continued)
22:4n-6 Erythrocyte 0.58 ± 0.07 **1.58 ± 0.09 / 3↑ 0.53 ± 0.07 **0.85 ± 0.05 / 1.6↑ 0.56 ± 0.06 0.66 ± 0.08
Plasma PL 0.15 ± 0.05 *0.33 ± 0.08 / 2↑ 0.14 ± 0.07 ***0.48 ± 0.06 / 3.2↑ 0.15 ± 0.05 0.15 ± 0.04
Plasma TAG 0.30 ± 0.01 0.27 ± 0.01 0.20 ± 0.05 tr 0.31 ± 0.06 ***0.61 ± 0.02 / 2↑
Plasma ES 0.24 ± 0.04 tr tr tr tr tr
22:5n-6 Erythrocyte 0.23 ± 0.15 *0.55 ± 0.05 / 2.5↑ 0.22 ± 0.10 ***0.17 ± 0.03 / 1.3↓ 0.21 ± 0.12 ***0.53 ± 0.13 / 2.5↑
Plasma PL 0.20 ± 0.01 tr 0.23 ± 0.05 ***0.55 ± 0.01 / 2.4↑ 0.15 ± 0.05 tr
Plasma TAG tr tr tr 0.20 ± 0.01 tr tr
Plasma ES 0.10 ± 0.07 tr tr tr tr 0.20 ± 0.01
22:5n-3 Erythrocyte 1.32 ± 0.16 1.62 ± 0.27 1.22 ± 0.14 1.38 ± 0.09 1.12 ± 0.17 1.15 ± 0.27
Plasma PL 0.62 ± 0.13 ***0.92 ± 0.10 / 1.5↑ 0.60 ± 0.15 0.61 ± 0.08 0.67 ± 0.20 0.65 ± 0.06
Plasma TAG 0.50 ± 0.02 ***1.05 ± 0.13 / 2↑ 0.64 ± 0.08 0.74 ± 0.11 0.54 ± 0.06 ***0.25 ± 0.07 / 2↓
Plasma ES 0.15 ± 0.05 tr tr 0.36 ± 0.09 tr 0.17 ± 0.02
22:6n-3 Erythrocyte 5.53 ± 0.12 *3.93 ± 0.11 / 1.4↓ 4.53 ± 0.16 **2.22 ± 0.08 / 2↓ 5.38 ± 0.17 ***2.85 ± 0.53 / 1.9↓
Plasma PL 3.22 ± 0.47 4.45 ± 0.50 3.00 ± 0.70 3.27 ± 0.24 3.80 ± 0.80 4.27 ± 0.35
Plasma TAG 1.45 ± 0.13 *2.93 ± 0.09 / 2↑ 1.85 ± 0.40 2.46 ± 0.33 1.10 ± 0.10 ***3.25 ± 0.32 / 3↑
Plasma ES 1.65 ± 0.38 1.95 ± 0.11 1.35 ± 0.30 1.14 ± 0.12 1.74 ± 0.28 ***0.87 ± 0.14 / 2↓
Mean ± m, n = 10.
Note: TAG, triacylglycerols; PL, phospholipids; ES, esters of sterols; tr, traces less than 0.1%. Asterisks indicate significant differences of fatty acid contents between
rats from experimental group and corresponding control group: *for P < 0.05; **for P < 0.01, ***for P < 0.001. The numbers in boldface after the slash indicate the
change of the value for the experimental group relative to that of the control group in the number of times. The arrow ↓ indicates that the value decreased. The
arrow ↑ indicates that the value increased.
Zhukova et al. Lipids in Health and Disease 2014, 13:49 Page 5 of 8
http://www.lipidworld.com/content/13/1/49the share of 18:0 was decreased in TAG and increased in
PL. An increase of 18:1n-9 content was revealed in the
erythrocytes. A significant decrease in the relative contents
of 18:2n-6 was found in the TAG and PL (P < 0.001). The
TAG and PL had low level of 20:3n-9 and high contents of
20:5n-3 and 22:5n-3 (Table 2). A significant decrease in
the share of 20:4n-6 was detected in all studied lipid frac-
tions of the blood plasma (P < 0.001). The dynamics of
these fatty acids in erythrocytes on the 30th day of the nu-
tritional stress was characterized by an increase in the
shares of 14:0, 18:0, 20:4n-6 and 22:4n-6 and a decrease in
the levels of 18:2n-6 and 22:6n-3.
On the 90th day of the experiment the contents of the
fatty acids 15:0 and 20:3n-9 in PL and ES in the blood
plasma was decreased. The level of 18:0 was increased in
the PL and TG of the blood plasma and erythrocytes.
The share of 18:1n-9 was increased in the erythrocytes
and in ES of the blood plasma. A decreased content of
20:4n-6 was identified in plasma ES, whereas in blood
cells the level of 20:4n-6 and its predecessor 20:3n-6
were increased. In the erythrocytes, a fall of the level of
20:5n-3 was revealed on the background of its increase
in the ES and TG of the blood plasma. The relative con-
tents of 22:5n-3 and 22:6n-3 in lipids of the blood
plasma did not differ from those in the control group. In
blood cells, the levels of 22:5n-6 and 22:6n-3 were de-
creased, while the 22:4n-6 level was increased. There-
fore, the vector of changes in the PUFA composition of
plasma lipids and red blood cells had on the 90th day of
the experiment a reciprocal direction. An increase in theamounts of 20:5n-3, 22:6n-3, and 22:5n-6 in the blood
plasma was revealed with a simultaneous deficiency of
these fatty acids in cell membranes.
After 180 days of the high-fat diet, the FA profile of
plasma lipids in rats was characterized by a decrease in
the amounts of 14:0 and 15:0. The PUFA pool (except
PL) was depleted in 18:2n-6. The level of 18:1n-9
remained elevated. A deficiency of 20:4n-6 was detected
in ES. The contents of 20:5n-3 and 22:4n-6 in TAG was
increased. The level of 22:6n-3 remained unchanged in
PL, increased in TAG and decreased in ES of the plasma.
Paradoxical at first glance phenomenon of increasing
levels of C20 and C22 PUFA in lipids of the blood
plasma distinctly fits into the concept on the disorder of
FA transport. Violation of the receptor capture of the li-
poproteins by cells leads to a PUFA deficiency in cell
membranes and to compensatory activation of the pas-
sive transport of the saturated FAs. Indeed, the modifica-
tion of the FA composition of erythrocytes on the 180th
day of high-fat diet consumption was characterized by
increased levels of saturated acids (14:0, 16:0, 18:0),
lower contents of 18:2n-6, 20:5n-3, and 22:6n-3. We can
suggest that the indicator of deficit of the fatty acids n-6
and n-3 in cells may be an increased level of Mead acid
(20:3n-9) in the erythrocytes’ membranes.
Fatty acids of the rat liver
An increase of the content of 16:0 and a decrease in the
content of 18:0 were revealed in the FA composition of
the rat liver after 30 days of the high-fat load (Table 3).
Table 3 Fatty acid composition (wt%) of total lipids of rat
liver at a 30 day high-fat load
Fatty acid Control Experiment
14:0 0.60 ± 0.09 0.53 ± 0.02
15:0 0.36 ± 0.05 0.33 ± 0.02
16:0 19.08 ± 0.59 *25.10 ± 1.45
18:0 10.42 ± 1.04 **5.80 ± 0.45
18:1n-9 16.32 ± 1.13 ***33.90 ± 0.9
18:1n-7 2.76 ± 0.22 3.40 ± 0.32
18:2n-6 15.08 ± 1.05 *13.20 ± 0.63
18:3n-6 0.15 ± 0.09 *0.38 ± 0.02
18:3n-3 0.32 ± 0.02 0.27 ± 0.09
18:4n-3 0.02 ± 0.02 ***0.15 ± 0.05
20:2n-6 0.14 ± 0.02 ***0.65 ± 0.05
20:3n-6 0.82 ± 0.04 **1.33 ± 0.07
20:4n-6 11.72 ± 1.05 ***4.20 ± 0.26
20:5n-3 1.25 ± 0.05 ***0.50 ± 0.02
22:4n-6 0.10 ± 0.06 0.23 ± 0.09
22:5n-3 1.54 ± 0.10 ***0.75 ± 0.05
22:6n-3 10.34 ± 0.30 ***4.53 ± 0.43
Mean ± m, n = 10.
Note: Asterisks indicate significant differences of fatty acid contents between
rats from experimental group and control: *for P < 0.05; **for P < 0.01;
***for P < 0.001.
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culiarity of the experimental diet that was enriched with
this FA. Indeed, the dietary saturated FA and cholesterol,
i.e. effectors of expression of the transcription factors
(sterol regulatory element-binding protein, SREBP) in-
duce the synthesis of 16:0 and TAG and inhibit VLDL
production, thus causing steatosis of the liver [7]. The
increased content of 18:1n-9 was accompanied by a de-
crease in the concentration of 18:0; this might indicate
activation of Δ9-desaturase, which performs metabolic
conversion in the reaction of 18:0→ 18:1n-9. Moreover,
there occurred a simultaneous increase in the contents
of 18:3n-6 and 18:4n-3 and decrease in the contents of
20:4n-6, 20:5n-3, 22:5n-3, and 22:6n-3.
After 90 days of the experiment, the content of 14:0 in ES
of the liver was increased. The level of 16:0 was decreased in
all lipid fractions (Table 4). The level of 18:0 was increased
in PL and decreased in ES. The metabolic conversions of
the PUFA after 90 days of the experiment led to increase in
the contents of 18:1n-9 in PL, TAG, and ES; of 18:3n-3 in
TAG and EC; of 18:2n-6 in TAG, ES, and PL; of 20:5n-3 in
ES, and 20:3n-6 in PL and TAG. Decreased amounts of
20:4n-6 and 20:3n-9 were revealed in all lipid fractions of
the rat liver. The amount of 22:5n-3 was increased in TAG.
The maintenance of the levels of C20 and C22 PUFA n-3
and n-6 plays an important role in adaptation of the organ-
ism to their temporary alimentary limitation.On the 180th day of the high-fat load, the levels of
14:0, 16:0 and 18:0 in the ES of the liver were reduced.
The concentrations of 14:0 and 16:0 in TAG were de-
creased. Low concentrations of 22:4n-6 in PL and of
18:2n-6 and 20:5n-3 in TAG were found in rats’ liver.
The deficiency of 20:4n-6 was detected in all the studied
fractions of lipids. The content of 18:1n-9 was increased
in the ES, PL and TAG. The high level of 18:2n-6 in ES
and PL was maintained, but was not as distinctly pro-
nounced as that on the 90th day of the experiment. The
amount of 18:3 n-3 remained high only in the ES. The
results of our study on the FA composition of the rat’s
liver are well comparable to those that have been ob-
tained in the analysis of FA levels in lipids of the rats’
blood plasma. The data on distribution of 20:5n-3 and
20:3n-6 were an only exception. So, in the lipids of the
blood plasma, 20:5n-3 was identified mainly in TAG and
ES, while 20:3n-6 was detected in the PL. Such a redis-
tribution of the FA between the polar and neutral lipids
is necessary to maintain homeostasis of 20:5n-3, which
is precursor of oxylipins possessing vasoactive and anti-
inflammatory properties [24,25]. The FA composition of
the blood plasma lipids can be recognized as an indica-
tor of the metabolic transformations of fatty acids in the
liver. Similarity of the changes in the FA composition
that occur in the liver and in the blood plasma allows us
to confirm that the FA composition of the blood plasma
may be recognized as an indicator of the metabolic alter-
ations in fatty acids of the liver.
It is known that syntheses of TAG, PL and ES occur in
the body from the two main pools: from free FA of
plasma and from FA synthesized de novo in the liver [9].
The alimentary deficiency of the essential PUFA in the
high-fat diet launches the compensatory synthesis of en-
dogenous FA [8,9]. Effect of the alimentary lipids on the
gene expression represents an adaptive response to
changes in the quantity and type of the consumed fat.
The direct effect of the saturated FA is due to the inter-
action with the transcription factors. The high-fat diet
rich in saturated fatty acids (14:0, 16:0, and 18:0) induces
the expression of the lipogenetic genes (PGC-1β, SREBP
1c, and other) responsible for the de novo synthesis of
FA and their elongation, but also inhibits the assembly
of VLDL-TAG through suppression of the synthesis of
mRNA apo-proteins [6-8]. Correspondingly, a high-fat
load on the liver launches two physiologically opposite
processes; accumulation of exogenous saturated FA and
endogenous biosynthesis of monounsaturated FA and
PUFA.
Thus, the prolonged unbalanced diet rich in choles-
terol and saturated FA promotes the compensatory syn-
thesis of polyunsaturated fatty acids; this is confirmed by
an increase in concentrations of dihomo-γ-linolenic acid
20:3n-6, eicosapentaenoic acid 20:5n-3 and arachidonic
Table 4 The content of fatty acids in the liver of rats at a high-fat load
Fatty acid Lipids High-fat load
90 days 180 days
Control Experiment Control Experiment
14:0 PL 0.28 ± 0.04 0.26 ± 0.03 0.22 ± 0.04 0.20 ± 0.04
TAG 0.86 ± 0.09 *0.63 ± 0.03 / 1.3↓ 0.85 ± 0.06 *0.65 ± 0.05 / 1.3↓
ES 0.58 ± 0.12 ***1.2 ± 0.4 / 2↑ 0.61 ± 0.14 ***0.27 ± 0.03 / 2.1↓
16:0 PL 20.48 ± 0.47 ***17.56 ± 1.09 / 1.2↓ 20.51 ± 0.33 19.50 ± 0.27
TAG 26.47 ± 0.56 ***16.63 ± 0.43 / 1.6↓ 26.47 ± 0.56 ***19.14 ± 0.47 / 1.3↓
ES 49.65 ± 2.51 ***14.1 ± 4.1 / 3.5↓ 51.20 ± 1.95 ***11.2 ± 0.61 / 4↓
18:0 PL 18.97 ± 0.67 ***23.73 ± 0.81 / 1.2↑ 18.77 ± 0.67 19.8 ± 0.56
TAG 2.45 ± 0.05 3.3 ± 0.2 2.21 ± 0.01 2.4 ± 0.17
ES 6.18 ± 0.38 *4.7 ± 1.2 / 1.5↓ 6.27 ± 0.34 ***3.68 ± 0.43 / 2↓
18:1n-9 PL 4.71 ± 0.19 ***6.0 ± 0.2 / 1.2↑ 3.51 ± 0.24 ***8.64 ± 0.33 / 2↑
TAG 28.57 ± 3.06 **34.56 ± 1.09 / 1.2↑ 27.64 ± 1.24 ***46.06 ± 1.28 / 2↑
ES 15.57 ± 1.61 ***54.03 ± 4.66 / 3.6↑ 15.78 ± 1.54 ***57.7 ± 3.49 / 3.8↑
18:2n-6 PL 13.4 ± 0.44 ***18.20 ± 0.20 / 1.4↑ 13.2 ± 0.27 **14.90 ± 0.40 / 1.1↑
TAG 18.3 ± 0.7 ***27.86 ± 0.61 / 1.5↑ 18.0 ± 0.2 *16.5 ± 0.22 / 1.1↓
ES 6.85 ± 0.70 ***15.16 ± 1.5 / 2↑ 6.52 ± 0.21 **8.94 ± 0.19 / 1.3↑
18:3n-3 PL 0.15 ± 0.03 0.10 ± 0.05 0.12 ± 0.05 0.15 ± 0.05
TAG 0.72 ± 0.05 *1.04 ± 0.08 / 1.6↑ 0.69 ± 0.01 0.71 ± 0.15
ES 0.52 ± 0.12 ***1.1 ± 0.10 / 2.3↑ 0.49 ± 0.09 *0.85 ± 0.19 / 2↑
20:3n-9 PL 0.40 ± 0.09 0.25 ± 0.05 0.36 ± 0.06 0.27 ± 0.08
TAG 0.34 ± 0.08 tr 0.31 ± 0.08 0.32 ± 0.06
ES tr tr tr 0.28 ± 0.02
20:3n-6 PL 1.35 ± 0.09 ***2.96 ± 0.23 / 2.2↑ 1.51 ± 0.08 ***2.88 ± 0.23 / 2.2↑
TAG 0.46 ± 0.15 *1.03 ± 0.2 / 2↑ 0.39 ± 0.06 0.5 ± 0.06
ES 0.38 ± 0.16 tr 0.78 ± 0.11 ***0.3 ± 0.05 / 2.6↓
20:4n-6 PL 21.86 ± 0.68 *17.23 ± 1.46 / 1.2↓ 22.91 ± 0.21 *17.5 ± 1.56 / 1.2↓
TAG 3.11 ± 0.36 ***1.1 ± 0.05 / 3↓ 2.59 ± 0.51 ***0.78 ± 0.07 / 3.8↓
ES 4.90 ± 0.34 ***1.15 ± 0.28 / 4↓ 5.10 ± 0.21 ***1.2 ± 0.15 / 4↓
20:5n-3 PL 0.57 ± 0.05 0.6 ± 0.05 0.54 ± 0.05 0.69 ± 0.11
TAG 0.97 ± 0.13 0.7 ± 0.05 1.07 ± 0.17 ***0.40 ± 0.07 / 2.3↓
ES ***0.3 ± 0.03 / 1.6↑ 0.31 ± 0.1
22:4n-6 PL 0.35 ± 0.05 ***0.10 ± 0.01 / 3↓ 0.34 ± 0.05 *0.23 ± 0.02 / 1.5↓
TAG 0.38 ± 0.03 0.33 ± 0.03 0.36 ± 0.01 0.48 ± 0.26
ES 0.60 ± 0.01 tr 0.60 ± 0.01 tr
22:5n-3 PL 1.03 ± 0.08 1.13 ± 0.08 1.04 ± 0.086 0.83 ± 0.08
TAG 0.98 ± 0.09 ***2.13 ± 0.08 / 2↑ 0.90 ± 0.10 0.85 ± 0.16
ES 0.30 ± 0.01 ***0.10 ± 0.01 / 3↑ 0.34 ± 0.04 tr
22:6n-3 PL 8.30 ± 0.46 8.50 ± 0.45 7.95 ± 0.16 8.6 ± 0.97
TAG 3.08 ± 0.37 4.0 ± 0.3 3.21 ± 0.21 *2.8 ± 0.10 / 1.1↓
ES 0.50 ± 0.03 0.63 ± 0.18 0.56 ± 0.07 0.61 ± 0.07
Mean ± m, n = 10.
TAG, triacylglycerols; PL, phospholipids; ES, esters of sterols; tr, traces less than 0.1%. Asterisks indicate significant differences of fatty acid contents between rats
from experimental group and corresponding control group: *for P < 0.05; **for P < 0.01; ***for P < 0.001. The numbers in boldface after the slash indicate the
change of the value for the experimental group relative to that of the control group in the number of times. The arrow ↓ indicates that the value decreased. The
arrow ↑ indicates that the value increased.
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blood plasma and the liver. At the same time, because of
the disorder of the active apoB-100 receptor transport of
fatty acids contained in LDL, polyunsaturated fatty acids
synthesized de novo in the liver are not captured by the
peripheral organs’ cells. This fact is evidenced by the ex-
perimentally proved deficiency of PUFAs n-3 and n-6 in
erythrocytes at distinct accumulation of lipid fractions in
the blood plasma. An indicator of disorders of the block-
ade of lipoproteins, transporting polyunsaturated fatty
acids from the liver to other organs is an increased level
of the LDL cholesterol in the blood serum. The data ob-
tained in our experiment opens an opportunity to
understand the physiological role of the nutritional fac-
tors and some mechanisms of development of many
alimentary-dependent diseases, including atherosclerosis,
diabetes, and steatohepatitis.
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